|
|
Poll Results
MiniMed's Continuous Blood Glucose Monitoring system (CGMS) was just recommended for approval by an FDA panel. Are you interested in using it?
I am very interested in the CGMS and will try to get it as soon as it is available 24% (122)
I am interested in the CGMS, but will ask my doctor about it first 29% (151)
I am somewhat interested in the CGMS, but want to hear from others who have used it first 18% (95)
I am not interested in the CGMS because it is invasive 8% (41)
I am not interested in the CGMS for other reasons 19% (99)
MiniMed's Continuous Blood Glucose Monitoring system (CGMS) was just recommended for approval by an FDA panel. Are you interested in using it?
Poll dates: February 28 - March 7, 1999
Total Votes: 508MiniMed's Continuous Blood Glucose Monitoring system (CGMS) represents a potential revolution in blood sugar monitoring. Multiple finger-stick blood tests cannot provide a complete picture of the daily high and low blood sugars that people with diabetes experience. Only a continuous monitor can do that. As the first such product recommended for FDA approval, the CGMS will provide most people with the first look at what their daily blood sugars really are.
In it's present form, the CGMS will only provide a retrospective look at three days of blood sugar values. That data will provide you and your health care team with better insight into your diabetes management needs, and could help you make adjustments to your care.
|
|
|||
Last Updated: Wednesday March 16, 2005 15:36:14
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
By using this site, you agree to our Terms of Use, Legal Notice, Privacy Policy, and Safe Harbor Policy.
© Children with Diabetes, Inc. 1995-2013. Comments and Feedback.